Results 21 to 30 of about 3,431 (127)

Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)

Clinical and Applied Thrombosis/Hemostasis, 2021
Introduction Argatroban is licensed for patients with heparin-induced thrombocytopenia and is conventionally monitored by activated partial thromboplastin time (APTT) ratio.
Susan Guy, Steve Kitchen, Michael Makris, Rhona M. Maclean, Giorgia Saccullo, Joost J Vanveen   +5 more
doaj   +1 more source

Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses

Акушерство, гинекология и репродукция, 2021
After the vaccination campaign initiation in Europe and the UK, reports of rare cases of atypical thrombosis, including sinus vein thrombosis and splanchnic venous thrombosis, began to appear in association with the use of vector vaccines AstraZeneca ...
S. V. Akinshina, V. O. Bitsadze, J. Kh. Khizroeva, K. N. Grigorieva, E. V. Slukhanchuk, M. V. Tretyakova, V. I. Tsibizova, I. Elalamy, J.-C. Gris, B. Brenner, E. Grandone, C. Ay, A. D. Makatsariya   +12 more
doaj   +1 more source

COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) and Cerebral Venous Sinus Thrombosis (CVST)- Lessons for India

Annals of Indian Academy of Neurology, 2022
The COVID-19 pandemic evolved rapidly, overwhelming health care systems around the world. The cost to life and socioeconomic burden prompted a search for new treatments and vaccines.
Erum Khan, Shriya Bavishi, Arvind K Sharma, Vijay K Sharma, Vinay Goyal   +4 more
doaj   +1 more source

Vaccine-Induced Immune Thrombotic Thrombocytopenia following BNT162b2 mRNA COVID-19 Booster: A Case Report

Vaccines, 2023
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a life-threatening complication caused by platelet activation via platelet factor 4 (PF4) antibodies.
Tzu-Chien Lin, Pei-An Fu, Ya-Ting Hsu, Tsai-Yun Chen   +3 more
doaj   +1 more source

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) after SARS‐CoV‐2 vaccination: Two cases from Germany with unusual presentation

Clinical Case Reports, 2023
Vaccine‐induced immune thrombotic thrombocytopenia (VITT) is a rare clinical condition that has emerged during the mass immunization against SARS‐CoV‐2.
Rhea Edmonds, Linda Schönborn, Sunke Habben, Maria Paparoupa, Andreas Greinacher, Frank Schuppert   +5 more
doaj   +1 more source

Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia

Frontiers in Immunology, 2022
During the COVID-19 pandemic, vaccination is the most important countermeasure. Pharmacovigilance concerns however emerged with very rare, but potentially disastrous thrombotic complications following vaccination with ChAdOx1.
Nicole de Buhr, Nicole de Buhr, Tristan Baumann, Christopher Werlein, Leonie Fingerhut, Leonie Fingerhut, Leonie Fingerhut, Rabea Imker, Rabea Imker, Marita Meurer, Marita Meurer, Friedrich Götz, Paul Bronzlik, Mark P. Kühnel, Mark P. Kühnel, Danny D. Jonigk, Danny D. Jonigk, Johanna Ernst, Andrei Leotescu, Maria M. Gabriel, Hans Worthmann, Ralf Lichtinghagen, Andreas Tiede, Maren von Köckritz-Blickwede, Maren von Köckritz-Blickwede, Christine S. Falk, Karin Weissenborn, Ramona Schuppner, Gerrit M. Grosse   +28 more
doaj   +1 more source

A narrative review of vaccine-induced thrombotic thrombocytopenia in organ donation and transplantation: Current evidence and implications

Indian Journal of Transplantation, 2023
Vaccine-induced thrombotic thrombocytopenia (VITT) has been recently linked with coronavirus disease (COVID-19) vaccines. It becomes crucial for the transplant communities to have a rigorous approach for accepting VITT donors, as the reports of such ...
Vivek B Kute, Sanshriti Chauhan, Narayan Prasad, Hari Shankar Meshram   +3 more
doaj   +1 more source

A Case of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia

Journal of Community Hospital Internal Medicine Perspectives, 2021
SARS-CoV-2, which originated in China in late 2019, has spread rapidly resulting in a global pandemic. Multiple vaccines have been developed to help prevent COVID-19 infection.
Abhinandan Chittal, Shiavax Rao, Pallavi Lakra, Natalia Nacu, Christopher Haas   +4 more
doaj   +1 more source

Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report

Vaccines, 2021
Background and Objectives: Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines.
Albrecht Günther, Dirk Brämer, Mathias W. Pletz, Thomas Kamradt, Sabine Baumgart, Thomas E. Mayer, Michael Baier, Angelina Autsch, Christian Mawrin, Linda Schönborn, Andreas Greinacher, Thomas Thiele   +11 more
doaj   +1 more source

The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies

Haematologica, 2022
In order to improve the safety of COVID-19 vaccines, there is an urgent need to unravel the pathogenesis of vaccineinduced immune thrombotic thrombocytopenia (VITT), a severe complication of recombinant adenoviral vector vaccines used to prevent COVID ...
Caroline Vayne, Raghavendra Palankar, Sandra Billy, Stefan Handtke, Thomas Thiele, Charlotte Cordonnier, Claire Pouplard, Andreas Greinacher, Yves Gruel, Jérôme Rollin   +9 more
doaj   +1 more source